QL
ARQT icon

Quarry LP’s Arcutis Biotherapeutics ARQT Stock Holding History

Quarry LP’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,200
Closed -$34.8K – 1435
2025
Q4 		$34.8K Sell
1,200
-954
-44% -$24.4K 0.01% 761
2025
Q3 		$40.6K Sell
2,154
-10,436
-83% -$165K 0.01% 958
2025
Q2 		$177K Buy
12,590
+6,090
+94% +$85.4K 0.04% 384
2025
Q1 		$102K Sell
6,500
-8,500
-57% -$120K 0.03% 511
2024
Q4 		$209K Buy
+15,000
New +$164K 0.04% 242
2024
Q2 		– Sell
-17,000
Closed -$168K – 1795
2024
Q1 		$168K Buy
17,000
+14,000
+467% +$104K 0.07% 193
2023
Q4 		$9.69K Hold
3,000
– – ﹤0.01% 1082
2023
Q3 		$15.9K Buy
+3,000
New +$25.5K 0.01% 773

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return